QQQ   310.34 (+1.43%)
AAPL   159.28 (+1.19%)
MSFT   273.78 (+0.57%)
META   202.16 (+2.20%)
GOOGL   104.92 (+3.66%)
AMZN   100.61 (+2.97%)
TSLA   197.58 (+7.82%)
NVDA   261.99 (+1.15%)
NIO   9.27 (+5.94%)
BABA   83.70 (+3.33%)
AMD   95.93 (-0.91%)
T   18.54 (+0.27%)
F   11.72 (+4.83%)
MU   58.63 (+1.72%)
CGC   1.97 (+5.91%)
GE   92.18 (+2.51%)
DIS   96.54 (+2.46%)
AMC   4.41 (+3.28%)
PFE   40.66 (-0.37%)
PYPL   76.72 (+4.79%)
NFLX   305.79 (+0.22%)
QQQ   310.34 (+1.43%)
AAPL   159.28 (+1.19%)
MSFT   273.78 (+0.57%)
META   202.16 (+2.20%)
GOOGL   104.92 (+3.66%)
AMZN   100.61 (+2.97%)
TSLA   197.58 (+7.82%)
NVDA   261.99 (+1.15%)
NIO   9.27 (+5.94%)
BABA   83.70 (+3.33%)
AMD   95.93 (-0.91%)
T   18.54 (+0.27%)
F   11.72 (+4.83%)
MU   58.63 (+1.72%)
CGC   1.97 (+5.91%)
GE   92.18 (+2.51%)
DIS   96.54 (+2.46%)
AMC   4.41 (+3.28%)
PFE   40.66 (-0.37%)
PYPL   76.72 (+4.79%)
NFLX   305.79 (+0.22%)
QQQ   310.34 (+1.43%)
AAPL   159.28 (+1.19%)
MSFT   273.78 (+0.57%)
META   202.16 (+2.20%)
GOOGL   104.92 (+3.66%)
AMZN   100.61 (+2.97%)
TSLA   197.58 (+7.82%)
NVDA   261.99 (+1.15%)
NIO   9.27 (+5.94%)
BABA   83.70 (+3.33%)
AMD   95.93 (-0.91%)
T   18.54 (+0.27%)
F   11.72 (+4.83%)
MU   58.63 (+1.72%)
CGC   1.97 (+5.91%)
GE   92.18 (+2.51%)
DIS   96.54 (+2.46%)
AMC   4.41 (+3.28%)
PFE   40.66 (-0.37%)
PYPL   76.72 (+4.79%)
NFLX   305.79 (+0.22%)
QQQ   310.34 (+1.43%)
AAPL   159.28 (+1.19%)
MSFT   273.78 (+0.57%)
META   202.16 (+2.20%)
GOOGL   104.92 (+3.66%)
AMZN   100.61 (+2.97%)
TSLA   197.58 (+7.82%)
NVDA   261.99 (+1.15%)
NIO   9.27 (+5.94%)
BABA   83.70 (+3.33%)
AMD   95.93 (-0.91%)
T   18.54 (+0.27%)
F   11.72 (+4.83%)
MU   58.63 (+1.72%)
CGC   1.97 (+5.91%)
GE   92.18 (+2.51%)
DIS   96.54 (+2.46%)
AMC   4.41 (+3.28%)
PFE   40.66 (-0.37%)
PYPL   76.72 (+4.79%)
NFLX   305.79 (+0.22%)
NASDAQ:SPRO

Spero Therapeutics - SPRO Insider Trading & Ownership

$1.40
+0.02 (+1.45%)
(As of 03/21/2023 12:00 AM ET)
Add
Compare
Today's Range
$1.36
▼
$1.44
50-Day Range
$1.36
▼
$2.00
52-Week Range
$0.68
▼
$9.00
Volume
259,076 shs
Average Volume
412,649 shs
Market Capitalization
$49.10 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.33

Spero Therapeutics (NASDAQ:SPRO) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.36%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$647,669.48
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$4.33 M

SPRO Insider Buying and Selling by Quarter

Get SPRO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Spero Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Spero Therapeutics Insider Trades History

Export to Excel
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/3/2023Ankit MahadeviaCEOSell12,286$1.81$22,237.66797,832  
2/2/2023Sath ShuklaCFOSell9,504$1.83$17,392.32312,517  
2/2/2023Timothy KeutzerCOOSell3,394$1.86$6,312.84327,144  
9/22/2022Aquilo Capital Management, LlcMajor ShareholderSell1,901,796$2.25$4,279,041.003,419,435  
8/29/2022Sath ShuklaCFOSell6,017$0.89$5,355.1356,064  
4/26/2022Aquilo Capital Management, LlcMajor ShareholderBuy39,727$5.24$208,169.485,321,231  
3/30/2022Aquilo Capital Management, LlcMajor ShareholderBuy50,000$8.79$439,500.00  
(Data available from 1/1/2013 forward)












SPRO Insider Trading Activity - Frequently Asked Questions

Who is on Spero Therapeutics's Insider Roster?

The list of insiders at Spero Therapeutics includes Ankit Mahadevia, Aquilo Capital Management, Llc, Cristina Larkin, Sath Shukla, and Timothy Keutzer. Learn more on insiders at SPRO.

What percentage of Spero Therapeutics stock is owned by insiders?

4.36% of Spero Therapeutics stock is owned by insiders. Learn more on SPRO's insider holdings.

Which Spero Therapeutics insiders have been buying company stock?

The following insider purchased SPRO shares in the last 24 months: Aquilo Capital Management, Llc ($10,414,722.67).

How much insider buying is happening at Spero Therapeutics?

Insiders have purchased a total of 694,207 SPRO shares in the last 24 months for a total of $10,414,722.67 bought.

Which Spero Therapeutics insiders have been selling company stock?

The following insiders have sold SPRO shares in the last 24 months: Ankit Mahadevia ($138,877.66), Aquilo Capital Management, Llc ($4,279,041.00), Sath Shukla ($22,747.45), and Timothy Keutzer ($6,312.84).

How much insider selling is happening at Spero Therapeutics?

Insiders have sold a total of 1,940,997 Spero Therapeutics shares in the last 24 months for a total of $4,446,978.95 sold.

This page (NASDAQ:SPRO) was last updated on 3/21/2023 by MarketBeat.com Staff